PNL23 COST-UTILITY ANALYSIS FOR EARLY PATIENTS WITH PARKINSONS DISEASE TREATED BY DOPAMINE AGONISTS
May 1, 2005, 00:00
10.1016/S1098-3015(10)62837-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)62837-9/fulltext
Title :
PNL23 COST-UTILITY ANALYSIS FOR EARLY PATIENTS WITH PARKINSONS DISEASE TREATED BY DOPAMINE AGONISTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62837-9&doi=10.1016/S1098-3015(10)62837-9
First page :
Section Title :
Open access? :
No
Section Order :
274